ied in the REACTIV trial.144 Cost-effectiveness analysis showed that surgery was significantly more cost-effective
than both sclerotherapy and conservative management;
sclerotherapy was less cost-effective than surgery but was
still significantly more cost-effective than conservative
treatment.
The need for a period of compression treatment before
any intervention for simple varicose veins has been surrounded
by controversy. Although third-party payers often require a
trial of compression stockings, there is virtually no